These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38874717)

  • 61. Control of neuropathic pain by immune cells and opioids.
    Machelska H
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):559-70. PubMed ID: 21631408
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tritiated opioid receptor ligands as radiotracers.
    Tóth G; Mallareddy JR
    Curr Pharm Des; 2013; 19(42):7461-72. PubMed ID: 23448471
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of food-derived opioid peptides in the central nervous and gastrointestinal systems.
    Liu Z; Udenigwe CC
    J Food Biochem; 2019 Jan; 43(1):e12629. PubMed ID: 31353498
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Opioids in chronic pain.
    Przewłocki R; Przewłocka B
    Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Concise Review of Concepts in Opioid Pharmacology up to the Discovery of Endogenous Opioids.
    Cox BM
    Mol Pharmacol; 2020 Oct; 98(4):392-400. PubMed ID: 32234811
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Opioid therapy and immunosuppression: a review.
    Vallejo R; de Leon-Casasola O; Benyamin R
    Am J Ther; 2004; 11(5):354-65. PubMed ID: 15356431
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytokines and peripheral analgesia.
    Schäfer M
    Adv Exp Med Biol; 2003; 521():40-50. PubMed ID: 12617563
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Beta-endorphin as the endogenous regulator of immune processes].
    Chereshnev VA; Geĭn SV
    Ross Fiziol Zh Im I M Sechenova; 2009 Dec; 95(12):1279-90. PubMed ID: 20141040
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Endogenous Opioid System as a Pathway of Positive Emotions.
    Barenz J; O'Donnell M; Smith J
    Adv Neurobiol; 2024; 35():241-250. PubMed ID: 38874726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cellular mechanisms underlying the interaction between cannabinoid and opioid system.
    Parolaro D; Rubino T; Viganò D; Massi P; Guidali C; Realini N
    Curr Drug Targets; 2010 Apr; 11(4):393-405. PubMed ID: 20017730
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dynamic measurement of extracellular opioid activity: status quo, challenges, and significance in rewarded behaviors.
    Murphy NP
    ACS Chem Neurosci; 2015 Jan; 6(1):94-107. PubMed ID: 25585132
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more.
    Darland T; Heinricher MM; Grandy DK
    Trends Neurosci; 1998 May; 21(5):215-21. PubMed ID: 9610886
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.
    Mollica A; Pelliccia S; Famiglini V; Stefanucci A; Macedonio G; Chiavaroli A; Orlando G; Brunetti L; Ferrante C; Pieretti S; Novellino E; Benyhe S; Zador F; Erdei A; Szucs E; Samavati R; Dvrorasko S; Tomboly C; Ragno R; Patsilinakos A; Silvestri R
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):444-451. PubMed ID: 28097916
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antinociception by neutrophil-derived opioid peptides in noninflamed tissue--role of hypertonicity and the perineurium.
    Rittner HL; Hackel D; Yamdeu RS; Mousa SA; Stein C; Schäfer M; Brack A
    Brain Behav Immun; 2009 May; 23(4):548-57. PubMed ID: 19233260
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of endogenous opioids and their receptors in the immune system.
    Carr DJ
    Proc Soc Exp Biol Med; 1991 Nov; 198(2):710-20. PubMed ID: 1656470
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.
    Toll L; Bruchas MR; Calo' G; Cox BM; Zaveri NT
    Pharmacol Rev; 2016 Apr; 68(2):419-57. PubMed ID: 26956246
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Opioids--triggers of adaptive phenomenon of ischemic preconditioning of heart].
    Maslov LN; Naryzhnaia NV; Podoksenov IuK; Mrochek AG; Gorbunov AS; Tsibul'nikov SIu
    Ross Fiziol Zh Im I M Sechenova; 2014 Sep; 100(9):993-1007. PubMed ID: 25697009
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Opioids and the skin--where do we stand?
    Bigliardi PL; Tobin DJ; Gaveriaux-Ruff C; Bigliardi-Qi M
    Exp Dermatol; 2009 May; 18(5):424-30. PubMed ID: 19382313
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immune cell-mediated opioid analgesia.
    Machelska H; Celik MÖ
    Immunol Lett; 2020 Nov; 227():48-59. PubMed ID: 32814155
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Capsaicin inhibits the in vitro binding of peptides selective for mu- and kappa-opioid, and nociceptin-receptors.
    Wollemann M; Ioja E; Benyhe S
    Brain Res Bull; 2008 Sep; 77(2-3):136-42. PubMed ID: 18588953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.